These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19927153)

  • 1. Telmisartan improves endothelial dysfunction and renal autoregulation in Dahl salt-sensitive rats.
    Satoh M; Haruna Y; Fujimoto S; Sasaki T; Kashihara N
    Hypertens Res; 2010 Feb; 33(2):135-42. PubMed ID: 19927153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats.
    Kobayashi N; Ohno T; Yoshida K; Fukushima H; Mamada Y; Nomura M; Hirata H; Machida Y; Shinoda M; Suzuki N; Matsuoka H
    Am J Hypertens; 2008 May; 21(5):576-81. PubMed ID: 18437150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-Glutathionylation of endothelial nitric oxide synthase: beneficial effects of therapy with the AT1 receptor blocker telmisartan.
    Knorr M; Hausding M; Kröller-Schuhmacher S; Steven S; Oelze M; Heeren T; Scholz A; Gori T; Wenzel P; Schulz E; Daiber A; Münzel T
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2223-31. PubMed ID: 21757654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure.
    Yamamoto E; Kataoka K; Shintaku H; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2569-75. PubMed ID: 17932313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telmisartan protects against vascular dysfunction with peroxisome proliferator-activated receptor-γ activation in hypertensive 5/6 nephrectomized rats.
    Toba H; Wang J; Ohigashi M; Kobara M; Nakata T
    Pharmacology; 2013; 92(5-6):265-75. PubMed ID: 24281041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telmisartan improves vascular function and reduces platelet activation in rats with streptozotocin-induced diabetes mellitus.
    Schäfer A; Flierl U; Vogt C; Menninger S; Tas P; Ertl G; Bauersachs J
    Pharmacol Res; 2007 Sep; 56(3):217-23. PubMed ID: 17669665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: role of nuclear factor kappa B activation.
    Zhou MS; Schulman IH; Raij L
    J Hypertens; 2010 Mar; 28(3):527-35. PubMed ID: 19898250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In salt-sensitive hypertension, increased superoxide production is linked to functional upregulation of angiotensin II.
    Zhou MS; Adam AG; Jaimes EA; Raij L
    Hypertension; 2003 Nov; 42(5):945-51. PubMed ID: 12975388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telmisartan inhibits vasoconstriction via PPARγ-dependent expression and activation of endothelial nitric oxide synthase.
    Yuen CY; Wong WT; Tian XY; Wong SL; Lau CW; Yu J; Tomlinson B; Yao X; Huang Y
    Cardiovasc Res; 2011 Apr; 90(1):122-9. PubMed ID: 21156825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telmisartan attenuates monocrotaline-induced pulmonary artery endothelial dysfunction through a PPAR gamma-dependent PI3K/Akt/eNOS pathway.
    Li H; Lu W; Cai WW; Wang PJ; Zhang N; Yu CP; Wang DL; Liu BC; Sun W
    Pulm Pharmacol Ther; 2014 Jun; 28(1):17-24. PubMed ID: 24269521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
    Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
    Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal endothelial dysfunction and impaired autoregulation after ischemia-reperfusion injury result from excess nitric oxide.
    Guan Z; Gobé G; Willgoss D; Endre ZH
    Am J Physiol Renal Physiol; 2006 Sep; 291(3):F619-28. PubMed ID: 16571595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of telmisartan on VEGF-induced and VEGF-independent angiogenic responsiveness of coronary endothelial cells in normal and streptozotocin (STZ)-induced diabetic rats.
    Chaudagar KK; Mehta AA
    Clin Exp Hypertens; 2014; 36(8):557-66. PubMed ID: 24490705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats.
    Wenzel P; Schulz E; Oelze M; Müller J; Schuhmacher S; Alhamdani MS; Debrezion J; Hortmann M; Reifenberg K; Fleming I; Münzel T; Daiber A
    Free Radic Biol Med; 2008 Sep; 45(5):619-26. PubMed ID: 18539157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telmisartan improves endothelial function in patients with essential hypertension.
    Benndorf RA; Appel D; Maas R; Schwedhelm E; Wenzel UO; Böger RH
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):367-71. PubMed ID: 18049303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of cortical COX-2 in salt-sensitive hypertension: role of angiotensin II and reactive oxygen species.
    Jaimes EA; Zhou MS; Pearse DD; Puzis L; Raij L
    Am J Physiol Renal Physiol; 2008 Feb; 294(2):F385-92. PubMed ID: 18094033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal and vascular protective effects of telmisartan in patients with essential hypertension.
    Morimoto S; Yano Y; Maki K; Sawada K
    Hypertens Res; 2006 Aug; 29(8):567-72. PubMed ID: 17137211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan.
    Ucciferri C; Falasca K; Mancino P; Di Iorio A; Vecchiet J
    Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):491-8. PubMed ID: 22696876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncoupled endothelial nitric oxide synthase and oxidative stress in a rat model of pregnancy-induced hypertension.
    Mitchell BM; Cook LG; Danchuk S; Puschett JB
    Am J Hypertens; 2007 Dec; 20(12):1297-304. PubMed ID: 18047920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotective effect of angiotensin II type 1 receptor antagonist associated with bradykinin-endothelial nitric oxide synthase and oxidative stress in Dahl salt-sensitive hypertensive rats.
    Yoshida K; Kobayashi N; Ohno T; Fukushima H; Matsuoka H
    J Hypertens; 2007 Aug; 25(8):1633-42. PubMed ID: 17620960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.